Home > Financial Ratios > PAR DRUGS AND CHEMICALS

PAR DRUGS AND CHEMICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for PAR DRUGS AND CHEMICALS
Please provide your vote to see the results

PAR DRUGS AND CHEMICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 3.559.918.1310.973.91

What is the latest EV/Core EBITDA ratio of PAR DRUGS AND CHEMICALS ?

The latest EV/Core EBITDA ratio of PAR DRUGS AND CHEMICALS is 3.55 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20253.55
Mar20249.91
Mar20238.13
Mar202210.97
Mar20213.91

How is EV/Core EBITDA of PAR DRUGS AND CHEMICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 3.55
-64.18
Mar2024 9.91
21.89
Mar2023 8.13
-25.89
Mar2022 10.97
180.56
Mar2021 3.91 -

Other Financial Ratios of PAR DRUGS AND CHEMICALS


Compare EV/Core EBITDA ratio of peers of PAR DRUGS AND CHEMICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS ₹106.6 Cr 2% -6.8% -13.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,620.0 Cr 1% -0.9% 6.8% Stock Analytics
DIVIS LABORATORIES ₹176,087.0 Cr 1.8% -2.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹154,837.0 Cr 3.7% 6.5% 44.9% Stock Analytics
CIPLA ₹112,194.0 Cr 0% 4.7% -8% Stock Analytics
DR REDDYS LABORATORIES ₹106,328.0 Cr -0.2% 0.7% -3.4% Stock Analytics


PAR DRUGS AND CHEMICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS

2%

-6.8%

-13.4%

SENSEX

1.7%

1.3%

-7.3%


You may also like the below Video Courses